|
|
 |
|
| News Release |
|
|
Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. |
| 1998 Release |
|
| December 1, 1998 | |
Eisai's German Subsidiary Begins Sales of PARIET, a Proton Pump Inhibitor
| |
| November 30, 1998 | |
Eisai Launches "TAMBOCOR Injection 50mg" an Antiarrthymic Treatment
| |
| November 24, 1998 | |
Eisai Announces Production & Shipment Commencement of ARICEPT, an Alzheimer's Disease Treatment, From US Manufacturing Facility
| |
| November 10, 1998 | |
Eisai Announces Non-Consolidated Semiannual Financial Results for the Fiscal Year Ending March 31, 1999
| |
| November 10, 1998 | |
Notice of Consolidated Business Results Forecast Revision For the Fiscal Year Ending March 1999
| |
| October 22, 1998 | |
Toyama Chemical & Eisai Sign Co-development Licensing Agreement in Japan for Toyama's T-614, a New Treatment for Rheumatoid Arthritis Currently Under Development in Japan and in Foreign Countries
| |
| October 7, 1998 | |
Eisai's Proton Pump Inhibitor Receives Agreement For Approval in All European Union Member States
| |
| October 2, 1998 | |
Notice of Valuation Loss on Listed Marketable Securities and Business Results Forecast Revision
| |
| September 30, 1998 | |
Patent Registration Completed For SELBEX Gastritis Use Treatment
| |
| August 6, 1998 | |
Eisai Submits New Drug Application For Donepezil Hydrochloride (U.S./Western Europe Registered Trademark: ARICEPT) to the Japanese Ministry of Health and Welfare
| |
| August 5, 1998 | |
Eisai Launches "CHOCOLA EC", an Over the Counter Product, With Natural Type Vitamin E & Vitamin C
| |
| June 22, 1998 | |
Eisai Launches ARICEPT, an Alzheimer's Disease Treatment, in Asia
| |
| June 15, 1998 | |
Eisai Launches Myocardial Infarction Treatment "CLEACTOR"
| |
| June 2, 1998 | |
Eisai and Toprak Sign Agreement for Marketing of Pharmaceuticals in Turkey
| |
| May 21, 1998 | |
Eisai Announces Non-Consolidated and Consolidated Financial Results for the Fiscal Year Ended March 31, 1998
| |
| May 21, 1998 | |
Eisai Announces Proposal for Partial Amendment to the Articles of Incorporation to Enable Purchases of Eisai Stock
| |
| May 21, 1998 | |
Eisai Withdraws New Drug Application for E1077, an Antibiotic
| |
| May 13, 1998 | |
Eisai Receives Marketing Authorization For PARIET (rabeprazole sodium), A Proton Pump Inhibitor, From the U.K. Medicines Control Agency.
| |
| April 1, 1998 | |
Eisai Submits NDA For Aciphex - New Drug Developed to Treat Gastroesophageal Reflux Disease (GERD) and Ulcers
| |
| March 13, 1998 | |
Eisai Announces Launch of ARICEPT (donepezil hydrochloride), New Treatment for Alzheimer's Disease in France
| |
| February 27, 1998 | |
Notice of Dividend Payment for the Year Ending March 1998 (86th Fiscal Term)
| |
| January 8, 1998 | |
Eisai and Knoll AG Announce A License Agreement For A New Anti-Obesity Drug in Japan | |
| | | |
|
|
|
